Evidence map›Paper›PMID 30894947›Full record

ArticleJournal of dental sciences2016

Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants.

Yoshinari Morimoto, Chizuko Yokoe, Yuko Imai, Megumi Sugihara, Toshiko Futatsuki

Open access · goldAbstract read
In one paragraph

Article in Journal of dental sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yoshinari MorimotoDepartment of Anesthesiology, Graduate School of Dentistry, Kanagawa Dental University, Kanagawa, Japan.
Chizuko YokoeDepartment of Anesthesiology, Graduate School of Dentistry, Kanagawa Dental University, Kanagawa, Japan.
Yuko ImaiSpecial Patient Oral Care Unit, Kyushu University Hospital, Fukuoka, Japan.
Megumi SugiharaSpecial Patient Oral Care Unit, Kyushu University Hospital, Fukuoka, Japan.
Toshiko FutatsukiSpecial Patient Oral Care Unit, Kyushu University Hospital, Fukuoka, Japan.
Kyushu University Hospital · JPKanagawa Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background/purposeThe nonvitamin K antagonist oral anticoagulants direct-thrombin inhibitor dabigatran and the Xa inhibitors rivaroxaban and apixaban are now being used clinically. The course of the patients on these anticoagulants who underwent tooth extraction was assessed. MATERIALS AND

methodsThe medical charts of these patients were investigated. Tooth extraction was performed while maintaining conventional anticoagulant therapy.

resultsTwenty-three teeth were extracted in 19 patients, including two surgical extractions. Among the 19 patients, nine patients ingested rivaroxaban, six apixaban, and four dabigatran. One patient on rivaroxaban showed persistent postoperative bleeding following two surgical extractions. Mild oozing was observed in five patients (two on rivaroxaban and three on apixaban). There was no bleeding episode in the patients on dabigatran.

conclusionThe patients on rivaroxaban with a prolonged prothrombin time value have a higher risk of bleeding, especially undergoing surgical extraction. Apixaban correlates to neither activated partial thromboplastin time nor prothrombin time values and the countermeasures should be employed based on the clinical findings.

Indexed as

apixabandabigatranpostoperative bleedingrivaroxabantooth extraction

Identifiers

PMID30894947
PMCPMC6395147
OpenAlexW2222322269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.